Public Clinical Trials Registry
Page 2 of 2, showing 9 record(s) out of 29 total
| Protocol No | Public Title | Scientific Title | Date Submitted | Date approved | |
|---|---|---|---|---|---|
| CT268/2023 | OCIS Placebo Ring Study | MATRIX-003 Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Ring (IVR) Designs | 25-10-2023 11:27 | 30-10-2023 | View |
| CT269/2023 | A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections (STRIVE) Version 1.0 Dated 11 November 2022 | A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections (STRIVE) Trial 1: Appendix E-1: Shionogi Protease Inhibitor (S-217622) Trial | 13-11-2023 16:29 | 05-09-2024 | View |
| CT272/2024 | Pharmacokinetic study of a novel DTG/FTC/TAF dose ratio for children | Pharmacokinetic study of an optimized dose ratio of dolutegravir/emtricitabine/tenofovir alafenamide fumarate: expediting a UNIVERSAL first line regimen for all children living with HIV in Africa | 05-01-2024 09:54 | 07-11-2024 | View |
| CT273/2024 | STRIVE IMMUNUNE MODULATION TRIAL | A Multicentre, Adaptive, Randomised, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized patients with Respiratory Infections (STRIVE) Version 1.0, 11 November 2022 INSIGHT Protocol Number: 018 / ACTIV | 22-01-2024 10:28 | 26-02-2024 | View |
| CT275/2024 | GSK_ViiV_221163 | Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition. | 13-03-2024 09:24 | 01-01-1970 | View |
| CT280/2024 | The Friendship Bench Plus trial (FB+Trial) | Combining antidepressants with psychological therapy to improve depression outcome in Zimbabwe - the Friendship Bench Plus trial (FB+Trial) | 19-07-2024 18:14 | 01-08-2025 | View |
| CT278/2024 | An open-label, single-arm study to provide continued access to study drug to participants who have completed pediatric clinical studies involving Gilead HIV treatments: GS-US-380-6684 | An open-label, single-arm study to provide continued access to study drug to participants who have completed pediatric clinical studies involving Gilead HIV treatments | 05-06-2024 14:59 | 01-07-2025 | View |
| CT283/2024 | OPTImising Metabolic management on Integrase based ART (OPTIMAR) | A Phase III/IV factorial randomised double-blind trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin/ezetimibe versus pitavastatin, in patients with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with e | 28-10-2024 14:30 | 01-01-1970 | View |
| CT281/2024 | GRAdHIVNE1 Vaccine Trial | A Phase 1 Randomized Double Blinded Placebo Controlled, Dose Ranging Trial, of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine (GRAdHIVNE1 Vaccine), Administered to Healthy Adults Living without HIV and Living with HIV, in Southern Africa | 16-10-2024 13:42 | 03-07-2025 | View |